Centre Eugène Marquis

Rennes 8 trials 4 recruiting

8 Registered trials

4 Currently recruiting

Organisation

Centre Eugène Marquis

Location

Rennes, France

Identifier

ORL-000005497

Address

Avenue de la Bataille de Flandres Dunkerque, 35000, France

Departments

Médecine Nucléaire
Medical Oncology
Oncologie médicale
Oncology for pediatrics
Radiotherapy department

Clinical trials at this site (8)

Search interface

REGENOVAR: A Phase I/II Study of Ubamatamab Plus Carboplatin, Paclitaxel, and Bevacizumab as Salvage Therapy in Ovarian Cancer with Poor Res… Pending

2025-524232-20-00 Patients with poor prognostic ovarian cancers based on 7
Prognostic value of early assessment by ⁶⁸Ga-DOTATATE PET/CT for the treatment of well-differentiated grade 2 gastroenteropancreatic neuroen… Pending

2025-524942-87-00 Gastroenteropancreatic neuroendocrine tumors 6
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
First-in-human study of OT-A201 in patients with selected hematological malignancies and solid tumors Recruiting

2024-511936-28-00 Relapsed/refractory hematological malignancies or adva 1 2023-05-12
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16
An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult P… Ended

2024-510995-18-00 Advanced Solid Tumors 1 2023-03-01